PTN vs PTIXW: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

PTN has stronger fundamentals based on our AI analysis.

PTN
PALATIN TECHNOLOGIES INC
STRONG SELL
95%
Confidence
VS
PTIXW
Protagenic Therapeutics, Inc.new
STRONG SELL
88%
Confidence

PTN vs PTIXW Fundamental Comparison

Metric PTN PTIXW
Revenue $9.0M $0.0
Net Income $-2.6M $-3.7M
Net Margin -28.9% N/A
ROE -22.6% N/A
ROA -14.4% -83.9%
Current Ratio 2.76x 0.34x
Debt/Equity 0.00x N/A
EPS $-1.47 $-1.50

Green = Better metric | Red = Weaker metric

View Full PTN Analysis →
View Full PTIXW Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

PTN vs AAPL PTIXW vs MSFT PTN vs GOOGL PTIXW vs AMZN

PTN vs PTIXW: Frequently Asked Questions

Is PTN or PTIXW a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), PTN has stronger fundamentals. PTN is rated STRONG SELL (95% confidence) while PTIXW is rated STRONG SELL (88% confidence). This is not investment advice.

How does PTN compare to PTIXW fundamentally?

PALATIN TECHNOLOGIES INC has ROE of -22.6% vs Protagenic Therapeutics, Inc.new's N/A. Net margins are -28.9% vs N/A respectively.

Which stock pays higher dividends, PTN or PTIXW?

PTN has a dividend yield of N/A or no dividend while PTIXW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in PTN or PTIXW for long term?

For long-term investing, consider that PTN has STRONG SELL rating with 95% confidence, while PTIXW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about PTN vs PTIXW?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PTN vs PTIXW, the AI consensus favors PTN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.